UnitedHealth Group's earnings call for Q3 2015 highlights solid short-term growth, with year-over-year revenue growth of 26.6% and a strong increase in Optum revenues. The management's tone is optimistic regarding strategic investments in Medicare stars quality, strong performance across its business segments, and a focus on innovation and efficiency. The challenges associated with the ACA exchanges are addressed with proactive measures for improvement in 2016. Given these results and strategies, UnitedHealth Group's stock is likely to experience positive momentum in the short term.

[1]